TMO vs DHR — Key Metrics

Metric TMO (THERMO FISHER SCIENTIFIC INC) DHR (DANAHER CORP)
Price692.74228.58
Market Cap256.67 Billion160.81 Billion
P/E (TTM)36.4837.35
P/B (Quarterly)4.7163.068
P/S (TTM)5.426.28
Net Profit Margin (TTM)14.916.9
Gross Margin (TTM)41.158.6
ROE (TTM)13.38.2
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

THERMO FISHER SCIENTIFIC INC
vs
 
DANAHER CORP
 
THERMO FISHER SCIENTIFIC INC
vs
 
DANAHER CORP
Performance Comparison
AI Model Recommendation
TMO · THERMO FISHER SCIENTIFIC INC

Greatly Underperform

-67
UnderperformOutperform
DHR · DANAHER CORP

Underperform

-49
UnderperformOutperform
Recommendation Summary

Stock TMO is projected to greatly underperform the market, stock DHR is projected to underperform the market. Upfront Recommendation: DHR.

Financial Metrics
Prices delayed ~15 min
TMO Metrics DHR
$692.74 Price $228.58
— Market Capitalization —
36.48 Price to Earnings Ratio 37.35
5.42 Price to Sales 6.28
33.61 Price to FCF Ratio 27.96
13.19 Price to Gross Profit 10.72
182.81 Price to R&D 96.3
10.02 Price to Current Assets 10.88

TMO vs DHR at a glance

Thermo Fisher Scientific INC (TMO) and Danaher Corp (DHR) are both Diagnostics & Research companies in the Healthcare sector. TMO is the larger, at $256.7 billion in market value against $160.8 billion for DHR, about 1.6 times the size.

On trailing-twelve-month figures, TMO trades at 36.5 times trailing earnings and DHR at 37.4; net profit margins are 14.9% and 16.9%.

The Upfront Investment model currently rates TMO Greatly Underperform and DHR Underperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.